The knockdown of PDE4D also increased the migration of bladder cancer cells and IFN-α (or TPL2 inhibitor) reduced the number of migrated cells only when the PDE4D protein was overexpressed (Additional file 6: Figure S6F-G). Here, MAP3K8 is linked to urinary bladder cancer.